DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PFIZER-E

« Back to Dashboard

Clinical Trials for Pfizer-e

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000159	Sorbinil Retinopathy Trial (SRT)	Completed	National Eye Institute (NEI)	Phase 3	To evaluate the safety and efficacy of the investigational drug sorbinil, an aldose reductase inhibitor, in preventing the development of diabetic retinopathy and neuropathy in persons with insulin-dependent diabetes.
NCT00000708	Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	N/A	To compare the safety and effectiveness of fluconazole (FCZ) and amphotericin B (AMB), alone or in combination with flucytosine (FLC), as treatment for acute cryptococcal meningitis in patients who have not been treated previously or who have relapsed after a previous successful treatment. Cryptococcal meningitis is an important cause of disease and death among patients with AIDS. Usually AMB is given either alone or with FLC to patients with this infection, but these treatments are not always effective and both have toxic effects. Animal studies and preliminary studies in humans show that FCZ is active in cryptococcal meningitis and suggest that it may be less toxic than either AMB or FLC.
NCT00036270	Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane	Completed	Pfizer	Phase 3	To compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early breast cancer. This Pfizer sponsored trial is part of an international collaboration of investigators conducting 7 similar yet independent studies in 9 countries. This study is designed to be part of the larger TEAM trial where the data from these 7 studies will be combined. A pre-specified analysis of the pooled data will be conducted.

Clinical Trial Conditions for Pfizer-e

Condition Name

Condition Name for Pfizer-e
Intervention	Trials
Healthy	60
Healthy Volunteers	9
Diabetes Mellitus	6

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pfizer-e
Intervention	Trials
Diabetes Mellitus	12
Breast Neoplasms	9
Schizophrenia	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pfizer-e

Trials by Country

Trials by Country for Pfizer-e
Location	Trials
United States	554
Italy	138
India	58
Canada	51
Brazil	46

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pfizer-e
Location	Trials
Texas	35
California	32
Florida	30
New York	28
Missouri	21

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pfizer-e

Clinical Trial Phase

Clinical Trial Phase for Pfizer-e
Clinical Trial Phase	Trials
Phase 4	34
Phase 3	35
Phase 2/Phase 3	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pfizer-e
Clinical Trial Phase	Trials
Completed	130
Terminated	37
Recruiting	24

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pfizer-e

Sponsor Name

Sponsor Name for Pfizer-e
Sponsor	Trials
Pfizer	93
Dr. Reddy's Laboratories Limited	14
Ranbaxy Laboratories Limited	11

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pfizer-e
Sponsor	Trials
Industry	167
Other	126
NIH	6

Export unavailable in trial.
Subscribe for complete access.